MicrobeDx Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $507K

  • Investors
  • 3

MicrobeDx General Information

Description

Developer of a diagnostic platform designed to improve patient care for those suffering from urinary tract infections. The company's platform provides an analysis of the bacterial response to a multitude of antibiotics and is appropriate for testing most body fluids, such as urine, blood, cerebrospinal fluid, and peritoneal fluid, enabling doctors to identify the bacterium early and to avoid giving unnecessary prescriptions, thus improving patient care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 17866 Tramonto Drive
  • Pacific Palisades
  • Los Angeles, CA 90272
  • United States
+1 (416)
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 17866 Tramonto Drive
  • Pacific Palisades
  • Los Angeles, CA 90272
  • United States
+1 (416)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MicrobeDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 10-Oct-2021 $507K Completed Generating Revenue
6. Later Stage VC 29-Dec-2020 Completed Generating Revenue
5. Early Stage VC 27-Mar-2019 Completed Generating Revenue
4. Grant 15-May-2018 Completed Generating Revenue
3. Seed Round 20-Jan-2018 Completed Generating Revenue
2. Angel (individual) 05-May-2017 $400K $400K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view MicrobeDx’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MicrobeDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diagnostic platform designed to improve patient care for those suffering from urinary tract infections. T
Discovery Tools (Healthcare)
Los Angeles, CA
4 As of 2026

Solna, Sweden
 

Stockholm, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MicrobeDx Competitors (2)

One of MicrobeDx’s 2 competitors is Attgeno, a Venture Capital-Backed company based in Solna, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Attgeno Venture Capital-Backed Solna, Sweden
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden
You’re viewing 2 of 2 competitors. Get the full list »

MicrobeDx Patents

MicrobeDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240026469-A1 Methods for microbial identification in clinical specimens by differential ribosomal rna probe hybridization Pending 10-Nov-2020
US-20230365960-A1 Methods for lysis of cells within a sample Inactive 03-Feb-2020
CA-3145649-A1 Method for antibiotic susceptibility testing of blood samples Pending 29-Jul-2019
EP-4004227-A1 Method for antibiotic susceptibility testing of blood samples Pending 29-Jul-2019
EP-4004227-A4 Method for antibiotic susceptibility testing of blood samples Pending 29-Jul-2019 C12Q1/689
To view MicrobeDx’s complete patent history, request access »

MicrobeDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MicrobeDx Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
CARB-X University
U.S. Department of Health and Human Services Government
Magnify Accelerator/Incubator
To view MicrobeDx’s complete investors history, request access »

MicrobeDx FAQs

  • When was MicrobeDx founded?

    MicrobeDx was founded in 2015.

  • Where is MicrobeDx headquartered?

    MicrobeDx is headquartered in Los Angeles, CA.

  • What is the size of MicrobeDx?

    MicrobeDx has 4 total employees.

  • What industry is MicrobeDx in?

    MicrobeDx’s primary industry is Discovery Tools (Healthcare).

  • Is MicrobeDx a private or public company?

    MicrobeDx is a Private company.

  • What is MicrobeDx’s current revenue?

    The current revenue for MicrobeDx is .

  • How much funding has MicrobeDx raised over time?

    MicrobeDx has raised $6.71M.

  • Who are MicrobeDx’s investors?

    CARB-X, U.S. Department of Health and Human Services, and Magnify have invested in MicrobeDx.

  • Who are MicrobeDx’s competitors?

    Attgeno and Gesynta Pharma are competitors of MicrobeDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process